DOD Biotech PCL (BKK:DOD) Cyclically Adjusted PB Ratio: (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:DOD DOD Biotech PCL BKK:DOD
70 GF Score
Price ฿0.98
GF Value ฿1.67
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is DOD Biotech PCL Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


DOD Biotech PCL  (BKK:DOD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


DOD Biotech PCL Cyclically Adjusted PB Ratio Related Terms


DOD Biotech PCL Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL Cyclically Adjusted PB Ratio Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.60

DOD Biotech PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.60 0.62 0.00

BKK:DOD vs KHC, GIS: Cyclically Adjusted PB Ratio Comparison

For the Packaged Foods subindustry, DOD Biotech PCL's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DOD Biotech PCL Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's Cyclically Adjusted PB Ratio falls into.


BKK:DOD
70GF Score
DOD Biotech PCL BKK:DOD
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

DOD Biotech PCL's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, DOD Biotech PCL's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.951/333.9520*333.9520
=1.951

Current CPI (Jun. 2026) = 333.9520.

DOD Biotech PCL Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 0.744 241.432 1.029
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.989 246.819 1.338
201712 0.872 246.524 1.181
201803 0.950 249.554 1.271
201806 3.119 251.989 4.133
201809 3.296 252.439 4.360
201812 2.882 251.233 3.831
201903 2.968 254.202 3.899
201906 2.986 256.143 3.893
201909 3.056 256.759 3.975
201912 2.967 256.974 3.856
202003 3.028 258.115 3.918
202006 2.863 257.797 3.709
202009 3.032 260.280 3.890
202012 2.954 260.474 3.787
202103 3.086 264.877 3.891
202106 2.945 271.696 3.620
202109 2.998 274.310 3.650
202112 3.116 278.802 3.732
202203 3.114 287.504 3.617
202206 3.052 296.311 3.440
202209 3.026 296.808 3.405
202212 2.159 296.797 2.429
202303 2.123 301.836 2.349
202306 2.303 305.109 2.521
202309 2.329 307.789 2.527
202312 2.349 306.746 2.557
202403 2.349 312.332 2.512
202406 1.969 314.175 2.093
202409 1.986 315.301 2.103
202412 1.995 315.605 2.111
202503 2.055 319.799 2.146
202506 2.077 322.561 2.150
202509 2.099 324.800 2.158
202512 2.128 324.054 2.193
202603 2.086 330.213 2.110
202606 1.951 333.952 1.951

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿0.98 is trading 41.3% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Possible Value Trap.

Key valuation signals for BKK:DOD:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ฿1.67 vs. price of ฿0.98 (41.3% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
70GF Score

Get the complete analysis for BKK:DOD

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.98
Price
฿1.67
GF Value